Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice

Psychopharmacology

Volumn 219, Issue 3, 2012, Pages 805-814

  Gourley, Shannon L ^a,b,c   Espitia, Jonathan W ^a   Sanacora, Gerard ^a   Taylor, Jane R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; BDNF; Depression; EATT2; Extinction; GLT 1; Glutamate; Incentive; Riluzole

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; EXCITATORY AMINO ACID TRANSPORTER 2; FLUOXETINE; GLUTAMATE GLIAL TRANSPORTER 1; GLUTAMATE TRANSPORTER; RILUZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FORCED SWIMMING TEST; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADMINISTRATION, ORAL; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID TRANSPORTER 2; MALE; MICE; MICE, INBRED C57BL; MOTIVATION; RILUZOLE;

EID: 84856677157     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2403-4     Document Type: Article

References (52)

1. Adachi M, Barrot M, Autry AE, Theobald D, Monteggia LM (2008) Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 63:642-629
2. Autry AE, Grillo CA, Piroli GG, Rothstein JD, McEwen BS, Reagan LP (2006) Glucocorticoid reulgation of GLT-1 glutamate transporter isoform expression in rat hippocampus. Neuroendocrinology 83:371-379 (Pubitemid 44729794)
3. Azbill RD, Mu X, Springer JE (2000) Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res 871:175-180 (Pubitemid 30433869)
4. Banasr M, Duman RS (2007) Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets 6:311-320 (Pubitemid 351492092)
5. Banasr M, Duman RS (2008) Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psych 64:863-870
6. Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL, Sanacora G (2010) Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psych 15:501-511
7. Caldarone BJ, Karthigeyan K, Harrist A, Hunsberger JG, Witmack E, King SL et al (2003) Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice. Psychopharmacology (Berl) 170:94-101 (Pubitemid 37372483)
8. Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA (2002) cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22:3262-3268 (Pubitemid 35379213)
9. Coric V, Milanovic S, Wasylink S, Patel P, Malison R, Krystal JH (2003) Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder. Psychopharmacology 167:219-220 (Pubitemid 36628165)
10. Crowley JJ, Blendy JA, Lucki I (2005) Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology 183:257-264 (Pubitemid 41609278)
11. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP, Artymyshyn RP, Gardier AM, Gerald C, Antonijevic IA, Leonardo ED, Hen R (2009) Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62:479-493
12. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606 (Pubitemid 27306570)
13. Ferguson GA (1978) Statistical analysis in psychology and education. McGraw Hill, New York
14. Frizzo ME, Dall'Onder LP, Dalcin KB, Souza DO (2004) Riluzole enhances glutamate uptake in rat astrocyte cultures. Cell Mol Neurobiol 24:123-128 (Pubitemid 38233735)
15. Fumagalli E, Bigini P, Barbera S, De Paola M, Mennini T (2006) Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease. Exp Neurol 198:114-128 (Pubitemid 43243750)
16. Fumagalli E, Funicello M, Rauen T, Gobbi M, Mennini T (2008) Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur J Pharmacol 578:171-176 (Pubitemid 350309596)
17. Gourley SL, Taylor JR (2009) Regulation and reversal of a persistent depression-like syndrome in rodent. Current Protocols in Neuroscience, Chapter 9, Unit 9.32
18. Gourley SL, Wu FJ, Kiraly DD, Ploski JE, Kedves AT, Duman RS, Taylor JR (2008a) Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry 63:353-359
19. Gourley SL, Kiraly DD, Howell JL, Olausson P, Taylor JR (2008b) Acute hippocampal BDNF restores motivational and forced swim performance after corticosterone. Biol Psychiatry 64:884-890
20. Gourley SL, Wu FJ, Taylor JR (2008c) Corticosterone regulates pERK1/2 in a chronic depression model. Ann N Y Acad Sci 1148:509-514
21. Gourley SL, Kedves AT, Olausson P, Taylor JR (2009) A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF. Neuropsychopharmacology 34:707-716
22. Groves JO (2007) Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12:1079-1088 (Pubitemid 350191365)
23. Holmes PV (2003) Rodent models of depression: reexamining validity without anthropomorphic inference. Crit Rev Neurobiol 15:143-174 (Pubitemid 38160442)
24. Katoh-Semba R, Asano T, Euda H, Morishita R, Takeuchi IK, Inaguma Y, Kato K (2002) Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J 16:1328-1330
25. Klinger E, Barta SG, Kemble ED (1974) Cyclic activity changes during extinction in rats: a potential animal model of depression. Animal Learn Mem 2:313-316
26. Lowy MT, Gault L, Yamamoto BK (1993) Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J Neurochem 61:1957-1960 (Pubitemid 23317225)
27. Lowy MT, Wittenberg L, Yamamoto BK (1995) Effects of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. J Neurochem 65:268-274
28. Mathew SJ, Keegan K, Smith L (2005) Glutamate modulators as novel interventions for mood disorders. Rev Bras Psiquiatr 27:243-248 (Pubitemid 41337491)
29. Mathew SJ, Murrough JW, aan het Rot M, Collins KA, Reich DL, Charney DS (2010) Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. Int J Neuropyschopharmacol 13:71-82
30. Mayorga AJ, Lucki I (2001) Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacology 155:110-112 (Pubitemid 32295777)
31. Mineur YS, PicciottoMR, Sanacora G (2007) Antidepressant-like effects of ceftriaxone in male C57BL/6 J mice. Biol Psych 61:250-252 (Pubitemid 46072785)
32. Mirza NR, Bright JL, Stanhope KJ, Wyatt A, Harrington NR (2005) Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels? Psychopharmacology 180:159-168 (Pubitemid 40897082)
33. Munro G, Erichsen HK, Mirza NR (2007) Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety. Neuropsychopharmacology 53:609-618 (Pubitemid 47513167)
34. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547
35. O'Neil MF, Moore NA (2003) Animal models of depression: are there any? Hum Psychopharmacol 18:239-254 (Pubitemid 36722309)
36. Pekary AE, Sattin A, Blood J, Furst S (2008) TRH and TRH-like peptide expression in rat following episodic or continuous corticosterone. Psychoneuroendocrinology 2008:1183-1197
37. Pittenger C, Coric V, Banasr M, Bloch M, Krystal JH, Sanacora G (2008) Riluzole in the treatment of mood and anxiety disorders. CNS Drugs 22:761-786
38. Porsolt R, Le Pichon M, Jalfe M (1977) Depression: a new animal model sensitive to antidepressant treatment. Nature 266:730-732 (Pubitemid 8073804)
39. Rajkowska G, Miguel-Hidalgo JJ (2007) Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6:219-233 (Pubitemid 46916253)
40. Reagan LP, Rosell DR, Wood GE, Spedding M, Muñoz C, Rothstein J, McEwen BS (2004) Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci USA 101:2179-2184 (Pubitemid 38229035)
41. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433:73-77 (Pubitemid 40101145)
42. Sanacora G, Kendell SF, Fenton L, Coric V, Krystal JH (2004) Riluzole augmentation for treatment-resistant depression. Am J Psychiatry 161:2132
43. Sanacora G, Kendell SF, Levin Y, Simen AA, Fenton LR, Coric V, Krystal JH (2007) Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biol Psychiatry 61:822-825 (Pubitemid 46330247)
44. Shirayama Y, Chen AC-H, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261 (Pubitemid 35379212)
45. Singh J, Zarate CA, Krystal AD (2004) Case report: successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine. Psychopharmacology 173:227-228 (Pubitemid 38591170)
46. Sung B, Lim G, Mao J (2003) Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 23:2899-2910 (Pubitemid 36418626)
47. Taliaz D, Stall N, Dar DE, Zangen A (2010) Knockdown of brainderived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol Psychiatry 15:80-92
48. Willner P (1984) The validity of animal models of depression. Psychopharmacology 83:1-16 (Pubitemid 14141479)
49. Wood GE, Young LT, Reagan LP, Chen B, McEwen BS (2004) Stressinduced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci 101:3973-3978 (Pubitemid 38381087)
50. Yang CH, Huang CC, Hsu KS (2005) Behavioral stress enhances hippocampal CA1 long-term depression through the blockade of the glutamate uptake. J Neurosci 25:4288-4293
51. Zarate CA, Payne JL, Quiroz J, Sporn J, Denicoff KK, Luckenbaugh D, Charney DS, Manji HK (2004) An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 161:171-174 (Pubitemid 38419327)
52. Zarate CA, Quiroz JA, Singh JB, Denicoff KD, De Jesus G, Luckenbaugh DA, Charney DS, Manji HK (2005) An openlabel trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 57:430-432 (Pubitemid 40215774)